Notify me when GV 2019, L.P. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PRME | Prime Medicine, Inc. | Common Stock, par value $0.00001 per share | 12% | $91,756,239 | 16,562,498 | Alphabet Holdings LLC | 30 Sep 2025 | ||
| MAZE | MAZE THERAPEUTICS, INC. | Common Stock, par value $0.001 per share | 2.9% | $57,528,994 | -$42,419,680 | 1,388,583 | -42% | Alphabet Holdings LLC | 31 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|